• DE
  • EN
  • FR
  • IT
AZ Logo
  • Our medicines
    • Cardiovascular, Renal & Metabolism
      • Heart Failure
        • Forxiga® (Dapagliflozin)
      • Chronic Kidney Disease (CKD)
        • Forxiga® (Dapagliflozin)
      • Type 2 diabetes
        • Forxiga® (Dapagliflozin)
        • Xigduo® (Dapagliflozin/Metformin HCI)
      • Amyloidosis
        • Wainzua® (Eplontersen)
    • Respiratory & Immunology
      • COPD
        • Trixeo® (Formoterol/Glycopyrronium/Budesonid)
      • Eosinophilic granulomatosis with polyangiitis (EGPA)
        • Fasenra® (Benralizumab)
      • Systemic lupus erythematosus (SLE)
        • Saphnelo® (Anifrolumab)
      • Asthma
        • Fasenra® (Benralizumab)
        • Symbicort® (Budesonid/Formoterol)
        • Tezspire® (Tezepelumab)
    • Oncology & Hematology
      • Breast Cancer
        • Lynparza® (Olaparib)
        • Enhertu® (Trastuzumab Deruxtecan)
        • Truqap® (Capivasertib)
      • Hematology
        • Calquence® (Acalabrutinib)
      • Hepatocellular Carcinoma
        • Imfinzi® (Durvalumab) + Imjudo® (Tremelimumab)
      • Biliary Tract Cancer
        • Imfinzi® (Durvalumab)
      • Lung Cancer
        • Imfinzi® (Durvalumab)
        • Tagrisso® (Osimertinib)
        • Enhertu® (Trastuzumab Deruxtecan)
      • Ovarian Cancer
        • Lynparza® (Olaparib)
      • Endometrial Cancer
        • Imfinzi® (Durvalumab)
      • Prostate Cancer
        • Lynparza® (Olaparib)
      • Muscle Invasive Bladder Cancer
        • Imfinzi® (Durvalumab)
      • Pancreatic Cancer
        • Lynparza® (Olaparib)
      • Gastric Cancer & Gastroesophageal adenocarcinoma (GC/GEJC)
        • Enhertu® (Trastuzumab Deruxtecan)
        • Imfinzi® (Durvalumab)
      • Tumor Agnostic
        • Enhertu® (Trastuzumab Deruxtecan)
    • View all Medicines
  • Therapeutic Areas
    • Cardiovascular, Renal & Metabolism
      • Acute care
      • Chronic Kidney Disease (CKD)
      • Diabetes
      • Heart failure
    • Respiratory & Immunology
      • Asthma
      • COPD
      • Systemic lupus erythematosus (SLE)
    • Oncology
      • Breast Cancer
      • Liver and gallbladder cancer
      • Ovarian cancer
      • Haematology
      • Lung cancer
      • Breast cancer
  • Contact us
Login

  • User
  • Login

Login

Don’t have an account?


Register here

Please enter valid email id!
Password requirements: 6-15 characters, 1 uppercase letter, 1 number, and 1 special character (*! @ #)

Verify your email address before accessing the portal

Unregistered user

Already registered user. Log in with your existing password

Credentials provided invalid

Incorrect data entered. Check the data entered before sending the request

The values ​​entered do not match (too long or too short)

Mandatory fields not filled in

Mandatory fields not filled in correctly

Accept the terms and conditions of use

The user cannot be validated

User not yet validated. Try signing in after your account has been certified

The doctor cannot be validated

Incorrect password. The password does not match the current one

Email not sent

Email address is not valid. Check your email address

User not validated

The authentication system is temporarily unavailable

Problems connecting to the authentication service

Operation not supported by this client

Accept the AstraZeneca terms and conditions of use

Invalid authentication type. Check the type of authentication used

The doctor cannot be validated. Incorrect password. The password does not match the current one

I confirm that I am a Health Care Professional
Remember me

Forgot Password


Invalid user id or credentials provided for authentication.

Are you an Astrazeneca employee? click here
alt text alt text
Connessiallasalute.it

This website is intended for healthcare professionals in Switzerland only.

Cookie policy

Contact

Privacy notice

Terms of use

Report side effects

Report quality complaint

Medical enquiries